This is an automatically translated article.
Magaltab is used in the short and long term treatment of gastrointestinal symptoms, increased acid secretion. The drug contains Aluminum hydroxide and Magnesium hydroxide. Let's find out more details about the uses, usage and notes when using Magaltab through the article below.
1. What is Magaltab?
Magaltab belongs to the group of gastrointestinal drugs, made in the form of chewable tablets, packed in boxes of 10 blisters x 5 tablets, boxes of 30 blisters x 10 tablets and bottles of 50 tablets.
Magaltab medicine has the main ingredients Aluminum hydroxide and Magnesium hydroxide and other excipients.
2. Indications for taking Magaltab
Magaltab is used in the following cases:
Short and long term treatment of peptic ulcers. Prevention and relief of ulcer symptoms associated with gastrointestinal bleeding due to stress. Gastroesophageal reflux, reduced by increased acid secretion, increased gastric motility, intestinal irritation and spasms. Symptoms caused by increased stomach acid such as: flatulence, dyspepsia, gastritis, heartburn, duodenitis, esophagitis, slit hernia, improper diet, alcohol intoxication. Pain after surgery.
3. Dosage - How to take Magaltab
Magaltab is for oral use, the patient should chew the tablet. Tablets may be chewed during pain or after meals 20 to 1 hour at bedtime or as directed by your doctor.
Dosage of Magaltab for adults > 16 years old refer to the following:
Gastrointestinal ulcers and gastritis: 1-2 Magaltab tablets every 4 hours. Increase gastric acid secretion: 1-2 tablets of Magaltab after meals or as needed. Maximum use Magaltab 6 times / day. Do not take more than 12 Magaltab tablets/day.
4. Contraindications to the use of Magaltab
Magaltab should not be used in the following cases:
Closed-angle glaucoma. Paralytic ileus, pyloric stenosis. Severe kidney failure. Decrease blood phosphate. Children. Patients with hypersensitivity to Aluminum hydroxide and magnesium hydroxide or any of the excipients in the drug.
5. Magaltab drug interactions
Here are some reported drug interactions Magaltab, patients need to be careful when combining:
Anti-tuberculosis drugs such as Ethambutol and Isoniazid, Cycline, Fluoroquinolone, Lincosanide, antihistamines H2, Atenolol, Métoprolol, Propranolol, Chloroquine, Diflunisal, Digoxine, Diphosphonate, Fluorure Sodium, Prednisolone, Dexamethasone, Indomethasone, Ketoconazole, Lanzoprazole, Phenothiazine Neuroleptics, Penicillamine, Phosphore, Iron Salts, Sparfloxacin, Magaltab reduce the gastrointestinal absorption of these drugs. Kayexalate in combination with Magaltab reduces the binding of the resin to potassium, with the risk of metabolic alkalosis in patients with renal failure. Salicylate derivatives in combination with Magaltab increase renal excretion of salicylates due to urinary alkalinization.
6. Side effects when taking Magaltab
During the use of Magaltab, patients may experience some unwanted side effects such as:
Immune system disorders: Hypersensitivity reactions, itching, urticaria, angioedema, anaphylactic reactions. Digestive disorders: Diarrhea, constipation. Metabolism and nutrition disorders: Increased magnesium in the blood, increased aluminum in the blood, decreased phosphate in the blood. Using the drug in high doses can lead to bone resorption, hypercalciuria, osteomalacia.
7. Precautions when using Magaltab
Patients should note the following before using Magaltab for treatment.
Magaltab should be used with caution in patients with coronary insufficiency, heart failure or prostate enlargement. Magaltab is not used for cases of fructose intolerance, glucose or galactose malabsorption syndrome, or any case of sucrase-isomaltase deficiency because it contains sorbitol and sucrose. If the patient is on a low phosphorus diet, aluminum hydroxide can cause phosphorus deficiency. In patients with renal failure, serum concentrations of both aluminum and magnesium are increased, in these patients long-term use of Magaltab with high concentrations of aluminum and magnesium salts can lead to encephalopathy, dementia, anemia. Small red blood cells often worsen dialysis-induced osteoporosis. Aluminum hydroxide may not be safe in people with porphyria on dialysis. Magaltab should be used with caution in patients with diabetes because of the amount of sugar in the tablet. If Magaltab is used for more than 10 days, but symptoms persist or worsen, the patient should be screened for possible causes. and re-evaluate treatment. The article provides information about the drug Magaltab has any effect, dosage and note when using. To ensure safety for your health and maximize the effectiveness of your treatment, you need to take Magaltab exactly as directed by your doctor.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
